title: Plasma endothelin correlates with antiendothelial antibodies in patients with mixed connective tissue disease.
abstract: BACKGROUND
  Elevated circulating levels of the vasoactive peptide endothelin-1 have been reported in various cardiovascular disorders. Because these conditions are frequently associated with endothelial dysfunction and damage and the vasoconstrictor effect of endothelin-1 is believed to be produced at the local vascular level, it is uncertain whether circulating endothelin-1 is a causal factor in enhanced vascular tone or instead a marker of endothelial injury.
  
  
  RESULTS
  We tested whether elevated immunoreactive endothelin-1 could be detected by radioimmunoassay in plasma and whether endothelin-1 levels correlated with antiendothelial autoantibodies in patients with mixed connective tissue disease. Venous blood samples were collected from 21 patients in the morning after an overnight fast and before medication. The plasma immunoreactive endothelin-1 level was 2.7 +/- 0.5 pg/mL (range, 1.1 to 5.2 pg/ml; n = 9) and 7.3 +/- 1.5 pg/mL (range, 2.8 to 20.7 pg/mL; n = 12) in patients who had no antiendothelial antibodies and in patients with antiendothelial antibodies, respectively. These latter values were significantly (P < .001) increased compared with 10 age-matched healthy volunteers (2.0 +/- 0.3 pg/mL; range, 0.5 to 3.0 pg/mL). Plasma endothelin-1 level strongly correlated with antiendothelial antibodies (rs = .836, n = 21, P < .001), whereas there was no correlation between age, systolic and diastolic blood pressures, antinuclear antibodies, and duration of the disease and endothelin-1 values. The incidence of Raynaud's phenomenon and angina did not differ significantly in patients with low and high endothelin-1 levels.
  
  
  CONCLUSIONS
  This study showed that mixed connective tissue disease is associated with elevated plasma immunoreactive endothelin-1 and that endothelin-1 levels significantly correlate with antiendothelial autoantibodies. These findings suggest that increases in plasma endothelin-1 concentration may be secondary to vascular injury and do not necessarily represent enhanced susceptibility to vasoconstriction.
authors.affiliation: Research Center, University of Montréal, Quebec, Canada.
authors.forename: J G
authors.initials: JG
authors.lastname: Filep
authors.forename: E
authors.initials: E
authors.lastname: Bodolay
authors.forename: S
authors.initials: S
authors.lastname: Sipka
authors.forename: E
authors.initials: E
authors.lastname: Gyimesi
authors.forename: I
authors.initials: I
authors.lastname: Csipö
authors.forename: G
authors.initials: G
authors.lastname: Szegedi
mesh_terms: D000328:Adult; D000974:Antibodies, Antinuclear / Q000097:blood; D001323:Autoantibodies / Q000097:blood*; D016022:Case-Control Studies; D016232:Endothelins / Q000097:blood*; D004730:Endothelium, Vascular / Q000276:immunology*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008947:Mixed Connective Tissue Disease / Q000097:blood / Q000276:immunology* / Q000503:physiopathology; D011863:Radioimmunoassay; D011928:Raynaud Disease / Q000097:blood; D014661:Vasoconstriction / Q000502:physiology
chemical_list: D000974:Antibodies, Antinuclear; D001323:Autoantibodies; D016232:Endothelins